Clinical trials
Active, not recruiting Phase 2 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Mayo Clinic | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| University of Florida | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Annick Desjardins, MD | 1 |
| BPGbio | 1 |
| Bryan Allen | 1 |
| CNS Pharmaceuticals, Inc. | 1 |
| Cantex Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 46 |
| Gliosarcoma | 5 |
| Astrocytoma | 4 |
| Brain Neoplasms | 4 |
| Glioma | 4 |
| Recurrence | 2 |
| Cholangiocarcinoma | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Ependymoma | 1 |
| Marijuana Abuse | 1 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.